Sarwar Atif, Katas Haliza, Samsudin Siti Noradila, Zin Noraziah Mohamad
Centre for Drug Delivery Research, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur Campus, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.
Novel Antibiotic Research Group, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur Campus, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.
PLoS One. 2015 Apr 30;10(4):e0123084. doi: 10.1371/journal.pone.0123084. eCollection 2015.
Recently, the attention of researchers has been drawn toward the synthesis of chitosan derivatives and their nanoparticles with enhanced antimicrobial activities. In this study, chitosan derivatives with different azides and alkyne groups were synthesized using click chemistry, and these were further transformed into nanoparticles by using the ionotropic gelation method. A series of chitosan derivatives was successfully synthesized by regioselective modification of chitosan via an azide-alkyne click reaction. The amino moieties of chitosan were protected during derivatization by pthaloylation and subsequently unblocked at the end to restore their functionality. Nanoparticles of synthesized derivatives were fabricated by ionic gelation to form complexes of polyanionic penta-sodium tripolyphosphate (TPP) and cationic chitosan derivatives. Particle size analysis showed that nanoparticle size ranged from 181.03 ± 12.73 nm to 236.50 ± 14.32 nm and had narrow polydispersity index and positive surface charge. The derivatives and corresponding nanoparticles were evaluated in vitro for antibacterial and antifungal activities against three gram-positive and gram-negative bacteria and three fungal strains, respectively. The minimum inhibitory concentration (MIC) of all derivatives ranged from 31.3 to 250 µg/mL for bacteria and 188 to1500 µg/mL for fungi and was lower than that of native chitosan. The nanoparticles with MIC ranging from 1.56 to 25 µg/mLfor bacteria and 94 to 750 µg/mL for fungi exhibited higher activity than the chitosan derivatives. Chitosan O-(1-methylbenzene) triazolyl carbamate and chitosan O-(1-methyl phenyl sulfide) triazolyl carbamate were the most active against the tested bacterial and fungal strains. The hemolytic assay on erythrocytes and cell viability test on two different cell lines (Chinese hamster lung fibroblast cells V79 and Human hepatic cell line WRL68) demonstrated the safety; suggesting that these derivatives could be used in future medical applications. Chitosan derivatives with triazole functionality, synthesized by Huisgen 1,3-dipolar cycloaddition, and their nanoparticles showed significant enhancement in antibacterial and antifungal activities in comparison to those associated with native, non-altered chitosan.
最近,研究人员的注意力已转向具有增强抗菌活性的壳聚糖衍生物及其纳米颗粒的合成。在本研究中,使用点击化学合成了具有不同叠氮化物和炔基的壳聚糖衍生物,并通过离子凝胶化方法将其进一步转化为纳米颗粒。通过叠氮化物-炔基点击反应对壳聚糖进行区域选择性修饰,成功合成了一系列壳聚糖衍生物。壳聚糖的氨基部分在衍生化过程中通过邻苯二甲酰化进行保护,随后在最后解封以恢复其功能。通过离子凝胶化制备合成衍生物的纳米颗粒,以形成聚阴离子三聚磷酸五钠(TPP)和阳离子壳聚糖衍生物的复合物。粒度分析表明,纳米颗粒尺寸范围为181.03±12.73nm至236.50±14.32nm,具有窄的多分散指数和正表面电荷。分别在体外评估了这些衍生物和相应的纳米颗粒对三种革兰氏阳性和革兰氏阴性细菌以及三种真菌菌株的抗菌和抗真菌活性。所有衍生物对细菌的最低抑菌浓度(MIC)范围为31.3至250μg/mL,对真菌为188至1500μg/mL,均低于天然壳聚糖。对细菌的MIC范围为1.56至25μg/mL、对真菌为94至750μg/mL的纳米颗粒表现出比壳聚糖衍生物更高的活性。壳聚糖O-(1-甲基苯)三唑基氨基甲酸酯和壳聚糖O-(1-甲基苯硫醚)三唑基氨基甲酸酯对测试的细菌和真菌菌株活性最高。对红细胞的溶血试验和对两种不同细胞系(中国仓鼠肺成纤维细胞V79和人肝细胞系WRL68)的细胞活力测试证明了其安全性;表明这些衍生物可用于未来的医学应用。通过Huisgen 1,3-偶极环加成合成的具有三唑功能的壳聚糖衍生物及其纳米颗粒与天然未改性的壳聚糖相比,在抗菌和抗真菌活性方面有显著增强。